Variant report
Variant | nsv522651 |
---|---|
Chromosome Location | chr3:23181557-23188043 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145349657 | chr3:23184623-23184624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553667866 | chr3:23184657-23184658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7643633 | chr3:23184693-23184694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542030705 | chr3:23184708-23184709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115290003 | chr3:23184709-23184710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575169155 | chr3:23184712-23184713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116028087 | chr3:23184720-23184721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114498408 | chr3:23184759-23184760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs117336979 | chr3:23184760-23184761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs112733718 | chr3:23184833-23184834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528130283 | chr3:23184838-23184839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539846685 | chr3:23184844-23184845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116573082 | chr3:23184856-23184857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs529158849 | chr3:23184878-23184879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375964335 | chr3:23184942-23184943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114601478 | chr3:23184949-23184950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149183666 | chr3:23184964-23184965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532960704 | chr3:23184999-23185000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552673097 | chr3:23185058-23185059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs570847570 | chr3:23185069-23185070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs180780360 | chr3:23185072-23185073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552910488 | chr3:23185090-23185091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544146371 | chr3:23185097-23185098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568430387 | chr3:23185105-23185106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577630319 | chr3:23185108-23185109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535719784 | chr3:23185113-23185114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs13317243 | chr3:23185162-23185163 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs186482102 | chr3:23185163-23185164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs207463056 | chr3:23185183-23185184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560644216 | chr3:23185239-23185240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575470271 | chr3:23185246-23185247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188621516 | chr3:23185277-23185278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557882786 | chr3:23185299-23185300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs199573626 | chr3:23185319-23185320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs375874497 | chr3:23185327-23185328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540230232 | chr3:23185354-23185355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs561630521 | chr3:23185394-23185395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529734417 | chr3:23185399-23185400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540517197 | chr3:23185414-23185415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529658057 | chr3:23185418-23185419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181730193 | chr3:23185419-23185420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544546407 | chr3:23185422-23185423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4411907 | chr3:23185435-23185436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4381964 | chr3:23185440-23185441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147965059 | chr3:23185442-23185443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551282146 | chr3:23185446-23185447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs4478098 | chr3:23185450-23185451 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs186084592 | chr3:23185477-23185478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190453107 | chr3:23185483-23185484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568144521 | chr3:23185484-23185485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:23184600-23186400 | Enhancers | Dnd41 | blood |
2 | chr3:23184800-23185200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |